UNITED THERAPEUTICS CORP
UNITED THERAPEUTICS CORP (UTHR) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 1684 transactions totaling $674.4M, demonstrating a bearish sentiment with -$674.4M in net insider flow. The most recent transaction on Jan 21, 2026 involved a transaction of 1,220 shares valued at $0.
UTHR Insider Activity Summary
Who Is Buying UTHR Stock?
No significant insider buying has been recorded for UTHR in the recent period.
Who Is Selling UTHR Stock?
No significant insider selling has been recorded for UTHR in the recent period.
Is UNITED THERAPEUTICS CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for UTHR is bearish with an Insider Alignment Score of 0/100 and a net flow of -$674.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
UTHR Frequently Asked Questions
Understanding UTHR Insider Activity
Insider trading at UNITED THERAPEUTICS CORP (UTHR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading UTHR stock, having executed 1684 transactions in the past 90 days. The most active insider is Martine A. Rothblatt (Executive), who has made 1126 transactions totaling $449.5M.
Related Tools
Track UNITED THERAPEUTICS CORP Insider Activity
Get notified when executives and directors at UTHR file new Form 4 transactions